Suchergebnisse - "Rawal, Ravindra K"

PubPharm (122)

31

Natural products and their derivatives as cyclooxygenase-2 inhibitors

enthalten in: Future medicinal chemistry | 2018

von Chandel, P. | Rawal, R. | Kaur, R.

32

Pyrrolopyrimidines : An update on recent advancements in their medicinal attributes

enthalten in: European journal of medicinal chemistry | 2018

von Pathania, S. | Rawal, R.

33

Drug metabolizing enzymes and their inhibitors' role in cancer resistance

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2018

von Pathania, S. | Bhatia, R. | Baldi, A. | +2

34

Applications of various analytical techniques in quality control of pharmaceutical excipients

enthalten in: Journal of pharmaceutical and biomedical analysis | 2018

von Kumar, M. | Bhatia, R. | Rawal, R.

35

Molecular Docking Studies on Isocytosine Analogues as Xanthine Oxidase Inhibitors

enthalten in: Drug research | 2018

von Roy, S. | Narang, B. | Gupta, M. | +3

36

Metal-catalyzed synthetic strategies toward coumarin derivatives

enthalten in: Chemistry of heterocyclic compounds | 2018

von Bhatia, R. | Pathania, S. | Singh, V. | +1

37

Metal-catalyzed synthetic strategies toward coumarin derivatives

enthalten in: Chemistry of heterocyclic compounds | 2018

von Bhatia, R. | Pathania, S. | Singh, V. | +1

38

Metal-catalyzed synthetic strategies toward coumarin derivatives

enthalten in: Chemistry of heterocyclic compounds | 2018

von Bhatia, R. | Pathania, S. | Singh, V. | +1

39

Enasidenib : First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid Leukemia

enthalten in: Anti-cancer agents in medicinal chemistry | 2018

von Dogra, R. | Bhatia, R. | Shankar, R. | +2

40

Structure Based Drug Design : Clinically Relevant HIV-1 Integrase Inhibitors

enthalten in: Current topics in medicinal chemistry | 2018

von Kaur, M. | Rawal, R. | Rath, G. | +1